Summary of findings: Molecular‐targeted therapy plus chemotherapy vs chemotherapy alone
Progression‐free survival · people with advanced gastric cancer
Summary of findings: Molecular‐targeted therapy plus chemotherapy showed no clear difference in progression‐free survival compared with chemotherapy alone (low certainty).
1 finding from 1 review
- Molecular‐targeted first‐line therapy for advanced gastric cancer 2016 · Cochrane Headline outcomes onlyHR 0.9 [0.78, 1.04]11 studies · 4014 participantsLow